drugset / Trial / NCT02729168
Safety Study of Rabies Vaccine INDIRAB® Five Doses (0.5ml) Post Exposure Administered Intramuscularly
Completed
120 enrolled
Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products
Bharat Biotech International Limited · collab
NaSingle-groupOpen-labelPrevention
Summary
An open label, non-comparative bridging study to evaluate the safety of Rabies vaccine INDIRAB® in Healthy Vietnamese volunteer aged from 5 years old.
Timeline
- Start
- 2015-10
- Primary completion
- 2015-10
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Human rabies vaccine | Vaccine | 0.5 ml | Intramuscular |